Could a vaccine stop breast cancer before it starts? new trial launches
Prevention
Recruiting now
This early-stage trial is testing whether a vaccine targeting the MUC1 protein, combined with hormone therapy, can help prevent ductal carcinoma in situ (DCIS) from becoming invasive breast cancer. Fifty women with ER-positive DCIS will receive either hormone therapy alone or hor…
Phase 1 • Sponsor: Finn, Olivera, PhD • Aim: Prevention
Last updated Aug 20, 2026 00:00 UTC